Topics & People

Health conditions affecting metabolism, reported to affect a massive portion of the population.

Theoretical biological mechanisms to control the dosing of Yamanaka factors to prevent cancer.

Investor and co-founder of the life sciences company New Limit.

A biotechnology company focusing on epigenetic reprogramming.

A disease risk associated with the improper dosing of Yamanaka factors.

Adult cells genetically reprogrammed to an embryonic stem cell-like state for creating organoids.

Miniaturized versions of organs produced in vitro for testing drug responses.

Multipotent stem cells used as a delivery mechanism for gene therapies like FOXO3.

A progressive neurodegenerative disease targeted by new mitochondrial therapies.

A neurodegenerative disorder that could potentially be treated by mitochondrial therapy.

A developing therapy aimed at restoring the energy-producing function of cells using young donor mitochondria.

A mental disorder that could be triggered in predisposed individuals by psychedelics.